Compare MMI & SSII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | MMI | SSII |
|---|---|---|
| Founded | 1971 | N/A |
| Country | United States | India |
| Employees | N/A | N/A |
| Industry | Real Estate | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.2B |
| IPO Year | 2013 | N/A |
| Metric | MMI | SSII |
|---|---|---|
| Price | $27.82 | $5.34 |
| Analyst Decision | Sell | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $29.00 | N/A |
| AVG Volume (30 Days) | ★ 364.5K | 78.4K |
| Earning Date | 11-07-2025 | 10-28-2025 |
| Dividend Yield | ★ 1.78% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $751,284,000.00 | $36,066,457.00 |
| Revenue This Year | $11.94 | N/A |
| Revenue Next Year | $15.59 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 20.74 | ★ 158.36 |
| 52 Week Low | $27.35 | $3.02 |
| 52 Week High | $41.94 | $22.42 |
| Indicator | MMI | SSII |
|---|---|---|
| Relative Strength Index (RSI) | 36.79 | 32.40 |
| Support Level | $28.74 | $5.82 |
| Resistance Level | $29.65 | $6.30 |
| Average True Range (ATR) | 0.82 | 0.48 |
| MACD | -0.13 | -0.01 |
| Stochastic Oscillator | 13.28 | 7.48 |
Marcus & Millichap Inc is a national brokerage firm specializing in commercial real estate investment sales, financing, research, and advisory services. The company offers three primary services to its clients: commercial real estate investment brokerage, financing, and ancillary services, including other research, advisory, and consulting services. The company generates revenues by collecting fees on the sale and financing of commercial properties. These fees consist of commissions collected upon the sale of a property and fees collected from the placement of loans.
SS Innovations International Inc is a commercial-stage surgical robotics company focused on transforming patient lives by democratizing access to advanced surgical robotics technologies. The company designs, manufactures, and markets an advanced, next-generation, and affordable surgical robotic system called the SSi Mantra, and the instruments and accessories used with SSi Mantra to perform a wide range of soft-tissue, robotically assisted surgeries. The company earns the majority of its revenue from India.